Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - erythromycin lactobionate, quantity: 1.4882 g/g (equivalent: erythromycin, qty 1 g) - injection, powder for - excipient ingredients: - oral erythromycin is not considered to be the antibiotic of choice in severely ill patients.,erythromycin-link (sterile erythromycin lactobionate) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin. intravenous therapy should be replaced by oral administration at the appropriate time.,? upper respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae); haemophilus influenzae (many strains of h. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved).,? lower respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae).,? respiratory tract infections due to mycoplasma pneumoniae.,? skin and s

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydralazine hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; propylene glycol - hypertensive crises, especially during late pregnancy (pre-eclampsia and eclampsia).

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - acetylcysteine, quantity: 2 g - injection, concentrated - excipient ingredients: disodium edetate; water for injections; sodium hydroxide - antidote for paracetamol poisoning. ,acetylcysteine is indicated in the treatment of paracetamol overdose to protect against hepatotoxity.

Australia - English - Department of Health (Therapeutic Goods Administration)

link orthopaedics australia pty ltd - 32831 - uncoated knee femur prosthesis - the total condylar replacement femoral component is manufactured from cocrmo alloy. three (3) sizes are available for the left and right side, in widths ranging from 60 mm to 75 mm. femoral components have a modular taper connection for connection with modular stems. hinge knee prosthesis is linked by an axis mechanism. the femoral and tibial components are linked by the special anti-luxation device of the plateau without reducing the motional and rotational sequences the link endo-model evo knee system is a non-active, surgically-invasive, implantable device which is intended for long-term replacement of a diseased and/ or defective knee joint in the human body. it can be used with full-grown, anesthetized patients of any ethnic origin and sex. the link endo-model evo knee system is implanted with or without cement related to the selected implant version. the femoral component is generally indicated for use in mobility limiting diseases, fractures or defects of the knee joint, distal femur or proximal tibia which cannot be treated by conservative or osteosynthetic procedures. these include primary and secondary osteoarthritis; rheumatoid arthritis; revision after primary or revision total knee replacement, bone necrosis, varus and valgus deformity with contracture or laxity of the medial or lateral stabilizers; extreme cases of varus/valgus deformities or muscular deficiency; oncological and revision surgery in lower limb (in conjunction with the endo-model w/ endo-model evo-w and the megasystem-c).

Australia - English - Department of Health (Therapeutic Goods Administration)

link orthopaedics australia pty ltd - 33692 - rotating hinged total knee prosthesis - the tibial component of the hinge version is manufactured from cocrmo alloy. three (3) sizes are available in widths ranging from 60 mm to 75 mm. the tibial components have also a modular taper connection for connection with modular stems. the hinge knee prosthesis is linked by an axis mechanism. the link endo-model evo knee system is a non-active, surgically-invasive, implantable device which is intended for long-term replacement of a diseased and/ or defective knee joint in the human body. it can be used with full-grown, anesthetized patients of any ethnic origin and sex. the link endo-model evo knee system is implanted with or without cement related to the selected implant version. the tibial component is generally indicated for use in mobility limiting diseases, fractures or defects of the knee joint, distal femur or proximal tibia which cannot be treated by conservative or osteosynthetic procedures. these include primary and secondary osteoarthritis; rheumatoid arthritis; revision after primary or revision total knee replacement, bone necrosis, varus and valgus deformity with contracture or laxity of the medial or lateral stabilizers; oncological and revision surgery in lower limb (in conjunction with the endo-model w/ endo-model evo-w and the megasystem-c).

Australia - English - Department of Health (Therapeutic Goods Administration)

link orthopaedics australia pty ltd - 32831 - uncoated knee femur prosthesis - the total condylar replacement femoral component is manufactured from cocrmo alloy. three (3) sizes are available for the left and right side, in widths ranging from 60 mm to 75 mm. femoral components feature female tapers and have a modular taper connection for connection with modular stems. joint components are equipped with an anti-luxation device. the femoral and tibial components are linked by special anti-luxation device of the plateau without reducing motional and rotational sequences. the link endo-model evo knee system is a non-active, surgically-invasive, implantable device which is intended for long-term replacement of a diseased and/ or defective knee joint in the human body. it can be used with full-grown, anesthetized patients of any ethnic origin and sex. the link endo-model evo knee system is implanted with or without cement related to the selected implant version. the femoral component is generally indicated for use in mobility limiting diseases, fractures or defects of the knee joint, distal femur or proximal tibia which cannot be treated by conservative or osteosynthetic procedures. these include primary and secondary osteoarthritis; rheumatoid arthritis; revision after primary or revision total knee replacement, bone necrosis, varus and valgus deformity with contracture or laxity of the medial or lateral stabilizers; oncological and revision surgery in lower limb (in conjunction with the endo-model w/ endo-model evo-w and the megasystem-c).

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - adrenaline acid tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. entrip 50mg tablets are indicated only for the maintenance treatment of major depression (see precautions). nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.